ca en eu en en en en es en en fr nl fr en en en en en en en en en en en en en en en en en en en en en en en en en en fr en en en fr en en en fr en en en fr nl fr en en en fr fr en fr en en fr en nl nl en en fr en fr es en en en en fr fr en en fr fr fr en en fr en en fr en en fr en en en en en en en fr fr en fr fr ru en en fr en en nl fr en en en fr en fr eu fr en en en fr de nl fr fr en en en en en en en en es en fr en en
EGID (European Genomic Institute for Diabetes) is first and foremost an international research institute focused on diabetes (type 1 and 2), obesity and the associated risk factors, the purpose of which is to disseminate and promote the “research product”.
EGID is the first diabetes research institute of international visibility based in France and the only center in the world with such a vast field of action in its field: fundamental research, university training, continuing education, prevention, prediction, clinical applications, industrial development and promotion of public health actions.
Composed of 5 research units, EGID brings together a critical mass unique in France of more than 250 employees:
UMR 1011 “Nuclear receptors, cardiovascular disease and diabetes”
UMR 1190 “Translational Research on Diabetes”
UMR 1172 “Development and Plasticity of the Neuroendocrine Brain”
UMR 1177 “Drugs and Molecules for Living Systems”
EGID is intended to play a leading role globally in the area of diabetes, obesity and associated risk factors.
The fundamental mission of the institute will be to achieve major breakthroughs both in the better understanding of these diseases and in their diagnosis and therapeutic treatments.
Master “Diabetes and cardiovascular diseases”: Track of solid knowledge on the most recent approaches, technologies and research results in the field of diabetes and cardiometabolic diseases.
Master “Precision Health” : International course open to students of scientific, medical / pharmaceutical and (bio) informatics training.
EGID laboratories welcome students each year for the preparation of their doctoral thesis in the Lille Biology-Health Doctoral School.
Discover the list of theses in progress and theses defended over the last 5 years as well as the thesis subjects offered for mobility for the start of the 2021 academic year.
The “precision health” graduate programme offers a unique training in research excellence and aims to train students in innovative concepts that will guide the research and health of tomorrow.
It is open to biologists, physicians and pharmacists, as well as national and international (bio) computer scientists, to train the next generation of research leaders for academia, industry and the world of biotechnology.
EGID has high-performance platforms for genomics, immuno-phenotyping and bio-therapy of diabetes and has put them at the service of their regional, national and European partners in order to promote collaboration.
ADME-PK - Drug Design
The Equipex LIGAN-PM platform, directed by Philippe FROGUEL, is dedicated to the sequencing of the human genome. Our latest generation high-throughput sequencers are geared towards personalized sequencing of patients with frequent diseases (such as diabetes, obesity, cardiovascular disease, cancer, Alzheimer’s disease) or rare diseases (such as monogenic forms of diabetes and obesity, and familial forms of cancer).
Internet Website : http://ligan.good.cnrs.fr/presentation/la-plateforme-ligan/
DiabInnov is a research platform that helps companies and academic laboratories to research and develop innovative therapies for the treatment of metabolic diseases and their comorbidities, in order to significantly advance the therapeutic management of patients.
The “EGID Innovation” platform is a project hotel. Located in the heart of the EGID building, it is intended to house biotechnology companies that are developing their projects in synergy with EGID. It complements the services offered by hotels with traditional projects by providing access to an exceptional scientific environment (Labex), state-of-the-art equipment and technological platforms of excellence (Equipex).
The immuno-phenotyping platform is equipped with several state-of-the-art equipment : a sorting analyzer allowing the simultaneous purification of 6 cell populations and an analyzer by mass cytometry, a technique in full development making it possible to analyze simultaneously up to 42 markers.
David Dombrowicz (Team director) : david.dombrowicz@pasteur-lille.fr
Olivier Molendi-Coste (Technical manager and research engineer) : olivier.molendi-coste@inserm.fr
Laurent Pineau (Research engineer) : laurent.pineau@inserm.fr
ADME-PK - Drug Design
La caractérisation qualitative et quantitative des effets associés à l’administration d’un composé à un animal modèle est la clé de voûte du processus de découverte de médicaments. Cette étape est essentielle pour estimer un futur effet thérapeutique et évaluer le rapport risque-bénéfice d’un candidat médicament. À ce titre, elle constitue une étape nécessaire dans la plupart des projets d’innovation thérapeutique, avant de décider d’engager un candidat pour des essais cliniques.
Managers scientifiques : Pr. B. Déprez & Dr F. Leroux (florence.leroux@univ-lille.fr)
Manager opérationnel: C. Piveteau (catherine.piveteau@univ-lille.fr)
Diabete is a major cause of early death and disability
people with diabetes go undiagnosed
people will potentially be affected by diabetes in 2030
Our dates to remember
5th EGID Thematic School
The 5th EGID Thematic School entitled : « Metagenomics and metabolomics in metabolic diseases » will take place in Bruges (Belgium), on October 12-13-14, 2022. This fifth edition will gather high-leveled speakers […]
Find out more »
Fête de la science 2022
La 31e édition de la Fête de la science en Hauts-de-France se déroulera du 07 au 17 octobre 2022 dans de nombreuses communes de la région sur le thème suivant: "Changement […]
Find out more »
Musée d’Histoire Naturelle de Lille, 23 Rue Gosselet
Metabolic surgery: a new step towards precision medicine
Metabolic surgery: a new step towards precision medicine Raverdy V, Cohen RV, Caiazzo R, Verkindt H, Petry TBZ, Marciniak C, Legendre B, …
Symposium EGID 2021 The 2021 edition of our unmissable symposium will be held on December 14, 2021 at Lille Grand Palais. On …
PhD studentship The laboratory CNRS UMR1283/8199 “Génomique intégrative et Modélisation des Maladies Métaboliques” (Integrated genomics and metabolic diseases modelling) offers up a …
Think-Tank EGID 2021 On July 01, 2021, EGID Think-Tank took place at the Faculty of Dental Surgery of Lille.As usual, the discussions …
+33 (0)3 20 97 42 51
1 PLACE DE VERDUN
© EGID Copyright 2021. All Rights Reserved.
Nous utilisons des cookies. Veuillez consulter notre page de politique de confidentialité pour plus d'informations.